Gastrointestinal first-pass effect of furosemide in rats

被引:19
|
作者
Kim, EJ [1 ]
Han, KS [1 ]
Lee, MG [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Kwanak Gu, Seoul 151742, South Korea
关键词
D O I
10.1211/0022357001777487
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The first-pass effect of furosemide was investigated in rats. Furosemide intravenous solution (20 mg kg(-1) Lasix), was administered via the jugular vein and the portal vein, orally, and instilled directly into the duodenum of rats. The first-pass effects of furosemide by lung, heart, and liver seemed to be negligible in rats. The absolute bioavailability of furosemide was 28.9 and 48.3% after oral and intraduodenal administration, respectively. Based on the gastrointestinal (GI) recovery study, 68.3 and 69.5% of furosemide were found to have disappeared mainly due to absorption and/or metabolism from rat GI tract after oral and intraduodenal administration, respectively. The results indicate that gastrointestinal and intestinal first-pass effects of furosemide were approximately 40% (68.3-28.9%) and 20% (69.5-48. 3%) of the dose, respectively.
引用
收藏
页码:1337 / 1343
页数:7
相关论文
共 50 条
  • [1] Pharmacokinetics and first-pass effects of liquiritigenin in rats: low bioavailability is primarily due to extensive gastrointestinal first-pass effect
    Kang, H. E.
    Cho, Y. K.
    Jung, H. Y.
    Choi, K. Y.
    Sohn, S. I.
    Baek, S. R.
    Lee, M. G.
    XENOBIOTICA, 2009, 39 (06) : 465 - 475
  • [2] Liver and gastrointestinal first-pass effects of azosemide in rats
    Kim, J
    Kim, SH
    Lee, MG
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (09) : 878 - 883
  • [3] Intestinal first-pass effect of bumetanide in rats
    Kim, EJ
    Han, KS
    Lee, MG
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 194 (02) : 193 - 199
  • [4] Pulmonary first-pass effect of quercetin in rats
    Chen, X
    Zuo, Z
    Chow, MSS
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1068 - 1068
  • [5] FIRST-PASS METABOLISM OF OMEPRAZOLE IN RATS
    WATANABE, K
    FURUNO, K
    ETO, K
    OISHI, R
    GOMITA, Y
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (08) : 1131 - 1134
  • [6] Pharmacokinetics of celgosivir, a novel antiviral agent, following oral administration in rats: Determination of the gastrointestinal first-pass effect
    Rubinchik, Evelina
    Erfle, Douglas J.
    Clement, Jacob J.
    Pasetka, Chris J.
    GASTROENTEROLOGY, 2006, 130 (04) : A836 - A836
  • [7] Hepatic and gastrointestinal first-pass effects of vitexin-4-O-glucoside in rats
    Chen, Yinghui
    Zhang, Wenjie
    Li, Di
    Ai, Junjun
    Meng, Yihan
    Ying, Xixiang
    Kang, Tingguo
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2013, 65 (10) : 1500 - 1507
  • [8] Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects
    Choi, Young H.
    Kim, Sang G.
    Lee, Myung G.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (11) : 2543 - 2552
  • [9] Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats
    Kim, J
    Kim, EJ
    Han, KS
    Chang, MS
    Lee, MG
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (09) : 1031 - 1036
  • [10] Pharmacokinetics and first-pass metabolism of astaxanthin in rats
    Choi, Hye Duck
    Kang, Hee Eun
    Yang, Si Hyung
    Lee, Myung Gull
    Shin, Wan Gyoon
    BRITISH JOURNAL OF NUTRITION, 2011, 105 (02) : 220 - 227